Clinical Trials Insight: 700049934

Trial Profile

Clinical Trials Insight: 700049934

Planning
Phase of Trial: Phase III

Latest Information Update: 04 Mar 2010

At a glance

  • Drugs Interferon alpha (Primary)
  • Indications Influenza virus infections
  • Focus Registrational; Therapeutic Use
  • Sponsors Intas Pharmaceuticals
  • Most Recent Events

    • 04 Mar 2010 The trial is expected to start at the end of March 2010, as reported by Amarillo Biosciences.
    • 13 Oct 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top